CORMEDIX INC. (CRMD) Return on equity 2016–2025
CORMEDIX INC. (CRMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
40.2%FY2025 · since FY2016: -138.3% → 40.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 40.2% | +61.4 pp |
| FY2024 | -21.2% | — |
| FY2022 | -53.9% | -9.0 pp |
| FY2021 | -44.9% | +4.9 pp |
| FY2020 | -49.8% | +19.7 pp |
| FY2019 | -69.5% | +474.2 pp |
| FY2018 | -543.7% | -84.8 pp |
| FY2017 | -458.9% | -320.6 pp |
| FY2016 | -138.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice